Studies on ciprofloxacin therapy of experimental Legionnaires' disease (Q67918546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Studies on ciprofloxacin therapy of experimental Legionnaires' disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

main subject

legionnaires' disease

1 reference

R B Fitzgeorge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

D H Gibson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

R Jepras

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

A Baskerville

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

publication date

1 May 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

194-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

Activities of newer quinolones against Legionella group organisms

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Activities of newer quinolones against legionella group organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Antibiotic therapy of experimental airborne Legionnaires' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Experimental transmission of legionnaires' disease by exposure to aerosols of Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

A mobile form of the Henderson apparatus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

An apparatus for the study of airborne infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Aerosol infection of animals with strains of Legionella pneumophila of different virulence: comparison with intraperitoneal and intranasal routes of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Measurement of the respiratory volumes of laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

The respiratory retention of bacterial aerosols: experiments with radioactive spores

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Factors influencing the assay of antimicrobial drugs in clinical samples by the agar plate diffusion method

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

The laboratory control of antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Immunologic Factors Affecting the In-Vivo and In-Vitro Survival of the Legionnaires' Disease Bacterium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Persistence in serum and lungs of guinea pigs of erythromycin, gentamicin, chloramphenicol and rifampicin and their in-vitro activities against Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Legionnaires' disease in non-Legionnaires. A report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Susceptibility of Legionella pneumophila to twenty antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

Activated human monocytes inhibit the intracellular multiplication of legionnaires' disease bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2885%2992438-7

7 January 2021

10.1016/S0163-4453(85)92438-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3161954%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference